← back to search

Julien Camperi

Gene Therapy Laboratory · FR
Area of research
Molecular Biology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Chemistry, Workflow, Computer science, Process analytical technology, Chromatography, and Computational biology.
h-index
citations
62
works
9
NIH funding
primary concept
email

Recent publications

In-process analytics for IVT mRNA manufacturing: from process understanding to advanced process control
Frontiers in Bioengineering and Biotechnology 2026cited by 0position: lastdoi
Analytical Assessment of sgRNA Impurities and Their Impact on Functional Performance
Analytical Chemistry 2026cited by 0position: lastdoi
Exploring the potential of oligonucleotide mapping with liquid chromatography – mass spectrometry to study the primary structure of mRNA
TrAC Trends in Analytical Chemistry 2025cited by 6position: middledoi
Establishing Analytical Methods for <scp>RNA‐Based</scp> Therapeutics Characterization
2025cited by 2position: firstdoi
Multi‐dimensional technology – Recent advances and applications for biotherapeutic characterization
Journal of Separation Science 2024cited by 18position: middledoi
Assessing TCR identity, knock-in efficiency, and potency for individualized TCR-T cell therapy
Journal of Immunological Methods 2023cited by 3position: firstdoi
Monitoring multiple quality attributes of a complex Fc-fusion protein during cell culture production processes by mD-LC-MS peptide mapping
Talanta 2022cited by 16position: firstdoi
Real-time monitoring of antibody quality attributes for cell culture production processes in bioreactors via integration of an automated sampling technology with multi-dimensional liquid chromatography mass spectrometry
Journal of Chromatography A 2022cited by 16position: lastdoi
Comprehensive UHPLC- and CE-based methods for engineered Cas9 characterization
Talanta 2022cited by 1position: firstdoi
Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation
mAbs 2021cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Davy Guillarme · University of Geneva3 papers (2022–2025) · 3 papers (2022–2022) · 2 papers (2022–2022)Lu Dai · University of Kentucky2 papers (2021–2022)Zhilan Hu · Gene Therapy Laboratory1 papers (2023–2023)Wendy Sandoval · Genomic Health (United States)1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2022–2022) · 1 papers (2025–2025)Elaine Y. Lin · Boston Children's Hospital1 papers (2021–2021) · 1 papers (2021–2021)Deepak P. Patil · Gene Therapy Laboratory1 papers (2026–2026) · 1 papers (2021–2021) · 1 papers (2026–2026)Patrick G. Holder · Gene Therapy Laboratory1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2025–2025) · 1 papers (2021–2021) · 1 papers (2022–2022)Juan P. Rincon Pabon · University of Kansas1 papers (2021–2021)